Alerts will be sent to your verified email
Verify EmailCOHANCE
Cohance Lifesciences
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
17.0 . | 100.0 . | n/a |
Unclassified
|
|||
R&D as a % of Total Sales
|
1.57 % | 0.18 % | n/a |
Financials
|
|||
5 yr Average ROE
|
27.26 % | 7.82 % | 12.33 % |
5yr average Equity Multiplier
|
1.3 | 1.96 | 1.57 |
5yr Average Asset Turnover Ratio
|
0.61 | 0.61 | 0.52 |
5yr Avg Net Profit Margin
|
33.51 % | 6.45 % | 15.3 % |
Price to Book
|
20.58 | 2.69 | 5.69 |
P/E
|
136.39 | 36.54 | 53.06 |
5yr Avg Cash Conversion Cycle
|
70.98 Days | -39.98 Days | -6453.7 Days |
Inventory Days
|
76.62 Days | 74.06 Days | 20.52 Days |
Days Receivable
|
42.46 Days | 45.59 Days | 48.33 Days |
Days Payable
|
85.69 Days | 149.89 Days | -264.76 Days |
5yr Average Interest Coverage Ratio
|
47.81 | 3.78 | 16.15 |
5yr Avg ROCE
|
32.61 % | 8.15 % | 13.11 % |
5yr Avg Operating Profit Margin
|
43.1 % | 16.76 % | 29.04 % |
5 yr average Debt to Equity
|
0.09 | 0.55 | 0.15 |
5yr CAGR Net Profit
|
-1.08 % | 0.08 % | 4.15 % |
5yr Average Return on Assets
|
20.57 % | 4.12 % | 7.88 % |
Shareholdings
|
|||
Promoter Holding
|
66.41 % | 47.68 % | 52.68 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
6.41 % | -3.0 % | -17.61 % |
Change in Mutual Fund Holding (3 Yrs)
|
2.58 % | 5.97 % | 17.91 % |
Cohance Lifesciences
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|